SCHEMBL6697832

SCHEMBL6697832

CC(Oc1ccc(C(C)(O)C(=O)O)cc1)c1nc2ccc(Sc3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)cc2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 10/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 2/20 0.36
CYP1A2 P05177 2/20 0.36
NR1I2 O75469 1/20 0.36
MAPK14 Q16539 1/20 0.36
TRPV1 Q8NER1 1/20 0.33
KDR P35968 1/20 0.33
TEK Q02763 1/20 0.33
HTT P42858 1/20 0.33
MMP1 P03956 1/20 0.33
CYP2C19 P33261 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
CHEK2 O96017 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6699629 0.92 SCN10A (0.37) SCN10AMEN1KMT2ALMNACYP1A2
Hydrochloric Acid SCHEMBL6700556 0.91 SCN10A (0.36) SCN10AMEN1KMT2ALMNACYP1A2
SCHEMBL6544826 0.85 MEN1 (0.34) SCN10AMEN1KMT2ALMNACYP1A2
SCHEMBL6697827 0.84 ALDH1A1 (0.35) SCN10AMEN1KMT2ALMNACYP1A2
SCHEMBL6699623 0.81 CYP1A2 (0.35) SCN10AMEN1KMT2ALMNACYP1A2
SCHEMBL6701220 0.80 NPC1 (0.44) SCN10AMEN1KMT2ACYP1A2HTT
Hydrochloric Acid SCHEMBL6700552 0.80 MEN1 (0.35) SCN10AMEN1KMT2ALMNACYP1A2
Hydrochloric Acid SCHEMBL6702467 0.80 NPC1 (0.43) SCN10AMEN1KMT2ACYP1A2HTT
SCHEMBL6701382 0.79 PPARA (0.35) MEN1KMT2ALMNACYP1A2NR1I2
SCHEMBL6543663 0.78 PPARG (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040002512-A1 Alpha-substituted carboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2004-01-01 US claimed
US-20030069294-A1 Alpha-substituted carboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-04-10 US claimed
EP-1167357-A1 ALPHA-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES Sankyo Company, Limited (JP) 2002-01-02 EP claimed
US-20040002512-A1 Alpha-substituted carboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2004-01-01 US disclosed
US-6596751-B2 An insulin resistance improving agent, hypoglycemic agent, immunoregulatory agent, aldose reductase inhibitor, 5-lipoxygenase inhibitor, peroxidized lipid production suppressor, PPAR. activator, leukotriene antagonist, adipose SANKYO COMPANY LIMITED (JP) 2003-07-22 US disclosed
US-20030069294-A1 Alpha-substituted carboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-04-10 US disclosed
EP-1167357-A1 ALPHA-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES Sankyo Company, Limited (JP) 2002-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002512-A1 Alpha-substituted carboxylic acid derivatives SLC5A1, SLC2A1, GPR119 SCN10A 1236/4885MEN1 3577/4885KMT2A 1979/4885
US-20030069294-A1 Alpha-substituted carboxylic acid derivatives SLC5A1, SLC2A1, GPR119 SCN10A 1236/4885MEN1 3577/4885KMT2A 1979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.